66 HUDSON BOULEVARD EAST, NEW YORK, NY
Annual Report to Security Holders
Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance
Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
Pfizer Inc. Completes $500 Million Public Offering of Floating Rate Notes
Other Events
Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Certificate
Registration of Securities
SC TO-I
Tender Offer Statement by Issuer
Definitive Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Free Writing Prospectus
Specialized Disclosure Report
Automatic Shelf Registration Statement